Institutional Repository of Vilnius University
Rekombinantinių SARS-CoV-2 nukleokapsidės baltymo ir spyglio baltymo receptorių prijungiančio domeno klonavimas, raiška, gryninimas bei sąveikos su mažamolekuliniais junginiais tyrimas /
Abstract
dc:descriptionSARS-CoV-2 is a virus belonging to a large group of riboviruses - coronaviruses - pathogenic to animals and humans. Infection with this pathogen can lead to severe respiratory and other organ problems or even death. The rapid and uncontrolled spread of the global pandemic SARS-CoV-2 has led to a critical need for therapeutic measures and drugs against the disease caused by this virus. Although vaccines approved by health organizations and drug agencies are currently being used for prevention and drug re-profiling studies of previously approved antiviral drugs are actively conducted, high frequency of viral genome recombination andmutations may render the already researched inhibitors ineffective. For these reasons, new compounds with inhibitory effects at any of the essential stages of the viral replication cycle are constantly being sought. Two structural SARS-CoV-2 virion proteins were selected for this study: the nucleocapsid protein with the primary function of binding to viral genomic RNA, and a spike protein RBD that initiates the initial attachment of a virion to an infected cell and modulates viral and target cell membrane fusion process. The aim was to clone, express and purify recombinant proteins that would be suitable for further biophysical protein - ligand interaction studies. Recombinant nucleocapsid and spike protein RBD expression in various E. coli strains and growth conditions revealed the highest spike protein RBD expression in the Origami TM B(DE3) strain, and soluble nucleocapsid protein was obtained in cells of the BL21(DE3) pLysS strain maintaining cell growth at 20 ° C for 18 h. The expression of the target protein was induced with 1mM of IPTG. In the purification of the spike protein RBD, it was found that the use of the GST tag causes aggregation of the protein in the subsequent purification steps and is not optimal. Purification of the nucleocapsid protein by metallochelate chromatography using a hexahistidine tail has been shown to be efficient and a stable recombinant protein is obtained. Examination of the interactions of the nucleocapsid protein with the available sulfonamide inhibitors and oligonucleotides did not reveal any strongly interacting compounds that would significantly alter the melting point of the protein by stabilizing it.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bajarūnaitė, Urtė,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192981888&prefLang=en_US